enVVeno Medical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NVNO and other ETFs, options, and stocks.About NVNO
enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include VenoValve and enVVe.
CEORobert Andrew Berman
CEORobert Andrew Berman
Employees37
Employees37
HeadquartersIrvine, California
HeadquartersIrvine, California
Founded1999
Founded1999
Employees37
Employees37
NVNO Key Statistics
Market cap6.82M
Market cap6.82M
Price-Earnings ratio-0.29
Price-Earnings ratio-0.29
Dividend yield—
Dividend yield—
Average volume522.26K
Average volume522.26K
High today$0.34
High today$0.34
Low today$0.32
Low today$0.32
Open price$0.32
Open price$0.32
Volume347.24K
Volume347.24K
52 Week high$5.62
52 Week high$5.62
52 Week low$0.3011
52 Week low$0.3011
Stock Snapshot
The current enVVeno Medical(NVNO) stock price is $0.34, with a market capitalization of 6.82M. The stock trades at a price-to-earnings (P/E) ratio of -0.29.
As of 2025-12-23, enVVeno Medical(NVNO) stock has fluctuated between $0.32 and $0.34. The current price stands at $0.34, placing the stock +5.5% above today's low and -0.7% off the high.
enVVeno Medical(NVNO) shares are trading with a volume of 347.24K, against a daily average of 522.26K.
In the last year, enVVeno Medical(NVNO) shares hit a 52-week high of $5.62 and a 52-week low of $0.30.
In the last year, enVVeno Medical(NVNO) shares hit a 52-week high of $5.62 and a 52-week low of $0.30.
People also own
Based on the portfolios of people who own NVNO. This list is generated using Robinhood data, and it’s not a recommendation.